Corrigendum: Common genetic variation drives molecular heterogeneity in human iPSCs (Nature (2017) 546 (370-375) DOI: 10.1038/nature22403);Common genetic variation drives molecular heterogeneity in human iPSCs

Nature

Volumn 546, Issue 7658, 2017, Pages 370-375

  Kilpinen, Helena ^a,h   Goncalves, Angela ^b   Leha, Andreas ^b,i   Afzal, Vackar ^c   Alasoo, Kaur ^b   Ashford, Sofie ^d   Bala, Sendu ^b   Bensaddek, Dalila ^c   Casale, Francesco Paolo ^a   Culley, Oliver J ^e   Danecek, Petr ^b   Faulconbridge, Adam ^a   Harrison, Peter W ^a   Kathuria, Annie ^e   McCarthy, Davis ^a,f   McCarthy, Shane A ^b   Meleckyte, Ruta ^e   Memari, Yasin ^b   Moens, Nathalie ^e   Soares, Filipa ^d   Mann, Alice ^b   Streeter, Ian ^a   Agu, Chukwuma A ^b   Alderton, Alex ^b   Nelson, Rachel ^b   Harper, Sarah ^b   Patel, Minal ^b   White, Alistair ^b   Patel, Sharad R ^b   Clarke, Laura ^a   Halai, Reena ^b   Kirton, Christopher M ^b   Kolb Kokocinski, Anja ^b   Beales, Philip ^g   Birney, Ewan ^a   Danovi, Davide ^e   Lamond, Angus I ^c   Ouwehand, Willem H ^b,d,h   Vallier, Ludovic ^b,d   Watt, Fiona M ^e   Durbin, Richard ^b   Stegle, Oliver ^a   Gaffney, Daniel J ^b   more..

^a EUROPEAN BIOINFORMATICS INSTITUTE   (United Kingdom)

^b WELLCOME TRUST SANGER INSTITUTE   (United Kingdom)

^c UNIVERSITY OF DUNDEE   (United Kingdom)

^d UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^e GUY S HOSPITAL   (United Kingdom)

^f ST VINCENT'S INSTITUTE OF MEDICAL RESEARCH   (Australia)

^g UNIVERSITY COLLEGE LONDON   (United Kingdom)

^h NHS BLOOD AND TRANSPLANT   (United Kingdom)

ⁱ UNIVERSITY MEDICAL CENTER GÖTTINGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

TRANSCRIPTOME;

CELLS AND CELL COMPONENTS; GENETIC VARIATION; GENOMICS; HETEROGENEITY; MOLECULAR ANALYSIS; PHENOTYPE;

ARTICLE; CANCER GENETICS; CELL DIFFERENTIATION; CELL STRUCTURE; CONTROLLED STUDY; COPY NUMBER VARIATION; GENE DOSAGE; GENETIC HETEROGENEITY; GENETIC STABILITY; GENETIC TRAIT; GENETIC VARIABILITY; GENETIC VARIATION; GENOME ANALYSIS; GENOTYPE; HUMAN; HUMAN CELL; INDUCED PLURIPOTENT STEM CELL; NORMAL HUMAN; PHENOTYPE; PHENOTYPIC VARIATION; PRIORITY JOURNAL; ANTIBODY SPECIFICITY; CELL CULTURE; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; NUCLEAR REPROGRAMMING; QUALITY CONTROL; QUANTITATIVE TRAIT LOCUS;

IPS;

CELLS, CULTURED; CELLULAR REPROGRAMMING; DNA COPY NUMBER VARIATIONS; GENE EXPRESSION REGULATION; GENETIC VARIATION; GENOTYPE; HUMANS; INDUCED PLURIPOTENT STEM CELLS; ORGAN SPECIFICITY; PHENOTYPE; QUALITY CONTROL; QUANTITATIVE TRAIT LOCI; TRANSCRIPTOME;

EID: 85020793872     PISSN: 00280836     EISSN: 14764687     Source Type: Journal    
DOI: 10.1038/nature23012     Document Type: Erratum

References (93)

1. Sterneckert, J. L., Reinhardt, P. & Schöler, H. R. Investigating human disease using stem cell models. Nat. Rev. Genet. 15, 625-639 (2014).
2. Kim, K. et al. Epigenetic memory in induced pluripotent stem cells. Nature 467, 285-290 (2010).
3. Kim, K. et al. Donor cell type can influence the epigenome and differentiation potential of human induced pluripotent stem cells. Nat. Biotechnol. 29, 1117-1119 (2011).
4. Lister, R. et al. Hotspots of aberrant epigenomic reprogramming in human induced pluripotent stem cells. Nature 471, 68-73 (2011).
5. Nazor, K. L. et al. Recurrent variations in DNA methylation in human pluripotent stem cells and their differentiated derivatives. Cell Stem Cell 10, 620-634 (2012).
6. Rouhani, F. et al. Genetic background drives transcriptional variation in human induced pluripotent stem cells. PLoS Genet. 10, e1004432 (2014).
7. Burrows, C. K. et al. Genetic variation, not cell type of origin, underlies the majority of identifiable regulatory differences in iPSCs. PLoS Genet. 12, e1005793 (2016).
8. Vallier, L. et al. Signaling pathways controlling pluripotency and early cell fate decisions of human induced pluripotent stem cells. Stem Cells 27, 2655-2666 (2009).
9. Müller, F. J. et al. A bioinformatic assay for pluripotency in human cells. Nat. Methods 8, 315-317 (2011).
10. Danecek, P., & McCarthy, S. A., HipSci Consortium & Durbin, R. A method for checking genomic integrity in cultured cell lines from SNP genotyping data. PLoS ONE 11, e0155014 (2016).
11. Laurent, L. C. et al. Dynamic changes in the copy number of pluripotency and cell proliferation genes in human ESCs and iPSCs during reprogramming and time in culture. Cell Stem Cell 8, 106-118 (2011).
12. The International Stem Cell Initiative. Screening ethnically diverse human embryonic stem cells identifies a chromosome 20 minimal amplicon conferring growth advantage. Nat. Biotechnol. 29, 1132-1144 (2011).
13. Abyzov, A. et al. Somatic copy number mosaicism in human skin revealed by induced pluripotent stem cells. Nature 492, 438-442 (2012).
14. Mayshar, Y. et al. Identification and classification of chromosomal aberrations in human induced pluripotent stem cells. Cell Stem Cell 7, 521-531 (2010).
15. Taapken, S. M. et al. Karotypic abnormalities in human induced pluripotent stem cells and embryonic stem cells. Nat. Biotechnol. 29, 313-314 (2011).
16. Hussein, S. M. et al. Copy number variation and selection during reprogramming to pluripotency. Nature 471, 58-62 (2011).
17. Laurin, M. & Côté, J. F. Insights into the biological functions of Dock family guanine nucleotide exchange factors. Genes Dev. 28, 533-547 (2014).
18. Zhang, X. et al. FATS is a transcriptional target of p53 and associated with antitumor activity. Mol. Cancer 9, 244 (2010).
19. Lo, J. Y., Chou, Y. T., Lai, F. J. & Hsu, L. J. Regulation of cell signaling and apoptosis by tumor suppressor WWOX. Exp. Biol. Med. 240, 383-391 (2015).
20. Futreal, P. A. et al. A census of human cancer genes. Nat. Rev. Cancer 4, 177-183 (2004).
21. Duckett, C. S. et al. A conserved family of cellular genes related to the baculovirus iap gene and encoding apoptosis inhibitors. EMBO J. 15, 2685-2694 (1996).
22. Chia, N. Y. et al. A genome-wide RNAi screen reveals determinants of human embryonic stem cell identity. Nature 468, 316-320 (2010).
23. Belinky, F. et al. PathCards: multi-source consolidation of human biological pathways. Database (Oxford) 2015, bav006 (2015).
24. GTEx Consortium. The Genotype-Tissue Expression (GTEx) pilot analysis: multitissue gene regulation in humans. Science 348, 648-660 (2015).
25. Grundberg, E. et al. Mapping cis-and trans-regulatory effects across multiple tissues in twins. Nat. Genet. 44, 1084-1089 (2012).
26. Kundaje, A. et al. Integrative analysis of 111 reference human epigenomes. Nature 518, 317-330 (2015).
27. Xu, H. et al. ESCAPE: database for integrating high-content published data collected from human and mouse embryonic stem cells. Database (Oxford) 2013, bat045 (2013).
28. Giambartolomei, C. et al. Bayesian test for colocalisation between pairs of genetic association studies using summary statistics. PLoS Genet. 10, e1004383 (2014).
29. Dubois, P. C. et al. Multiple common variants for celiac disease influencing immune gene expression. Nat. Genet. 42, 295-302 (2010).
30. Stranger, B. E. et al. Population genomics of human gene expression. Nat. Genet. 39, 1217-1224 (2007).
31. Zeller, T. et al. Genetics and beyond-the transcriptome of human monocytes and disease susceptibility. PLoS One 5, e10693 (2010).
32. Purrington, K. S. et al. Genome-wide association study identifies 25 known breast cancer susceptibility loci as risk factors for triple-negative breast cancer. Carcinogenesis 35, 1012-1019 (2014).
33. Garcia-Closas, M. et al. Genome-wide association studies identify four ER negative-specific breast cancer risk loci. Nat. Genet. 45, 392-398 (2013).
34. Wang, Z. et al. Imputation and subset-based association analysis across different cancer types identifies multiple independent risk loci in the TERT-CLPTM1L region on chromosome 5p15. 33. Hum. Mol. Genet. 23, 6616-6633 (2014).
35. Li, Q. et al. Integrative eQTL-based analyses reveal the biology of breast cancer risk loci. Cell 152, 633-641 (2013).
36. Ongen, H. et al. Putative cis-regulatory drivers in colorectal cancer. Nature 512, 87-90 (2014).
37. Chen, Q. R., Hu, Y., Yan, C., Buetow, K. & Meerzaman, D. Systematic genetic analysis identifies cis-eQTL target genes associated with glioblastoma patient survival. PLoS One 9, e105393 (2014).
38. Bojesen, S. E. et al. Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer. Nat. Genet. 45, 371-384 (2013).
39. Chiba, K. et al. Cancer-associated TERT promoter mutations abrogate telomerase silencing. eLife 4, e07918 (2015).
40. Kyttälä, A. et al. Genetic Variability Overrides the Impact of Parental Cell Type and Determines iPSC Differentiation Potential. Stem Cell Reports 6, 200-212 (2016).
41. Kajiwara, M. et al. Donor-dependent variations in hepatic differentiation from human-induced pluripotent stem cells. Proc. Natl Acad. Sci. USA 109, 12538-12543 (2012).
42. Choi, J. et al. A comparison of genetically matched cell lines reveals the equivalence of human iPSCs and ESCs. Nat. Biotechnol. 33, 1173-1181 (2015).
43. Gerrits, A. et al. Expression quantitative trait loci are highly sensitive to cellular differentiation state. PLoS Genet. 5, e1000692 (2009).
44. Spies, N. et al. Constraint and divergence of global gene expression in the mammalian embryo. eLife 4, e05538 (2015).
45. Cannavò, E. et al. Genetic variants regulating expression levels and isoform diversity during embryogenesis. Nature 541, 402-406 (2017).
46. Carcamo-Orive, L. et al. Analysis of transcriptional variability in large human iPSC library reveals genetic and non-genetic determinants of heterogeneity. Cell Stem Cell 20, 518-532 (2017).
47. DeBoever, C. et al. Large-scale profiling reveals the influence of genetic variation on gene expression in human induced pluripotent stem cells. Cell Stem Cell 20, 533-546 (2017).
48. Kim, N. W. et al. Specific association of human telomerase activity with immortal cells and cancer. Science 266, 2011-2015 (1994).
49. Kelly, L. M. & Gilliland, D. G. Genetics of myeloid leukemias. Annu. Rev. Genomics Hum. Genet. 3, 179-198 (2002).
50. ENCODE Project Consortium. An integrated encyclopedia of DNA elements in the human genome. Nature 489, 57-74 (2012).
51. Takahashi, K. & Yamanaka, S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126, 663-676 (2006).
52. The UK10K Consortium. The UK10K project identifies rare variants in health and disease. Nature 526, 82-90 (2015).
53. The 1000 Genomes Project Consortium. A global reference for human genetic variation. Nature 526, 68-74 (2015).
54. Howie, B. N., Donnelly, P. & Marchini, J. A flexible and accurate genotype imputation method for the next generation of genome-wide association studies. PLoS Genet. 5, e1000529 (2009).
55. Delaneau, O., Marchini, J. & Zagury, J. F. A linear complexity phasing method for thousands of genomes. Nat. Methods 9, 179-181 (2011).
56. Li, H. & Durbin, R. Fast and accurate short read alignment with Burrows-Wheeler transform. Bioinformatics 25, 1754-1760 (2009).
57. Harrow, J. et al. GENCODE: the reference human genome annotation for The ENCODE Project. Genome Res. 22, 1760-1774 (2012).
58. Huber, W., von Heydebreck, A., Sültmann, H., Poustka, A. & Vingron, M. Variance stabilization applied to microarray data calibration and to the quantification of differential expression. Bioinformatics 18 (Suppl 1), S96-S104 (2002).
59. Vallier, L. et al. Early cell fate decisions of human embryonic stem cells and mouse epiblast stem cells are controlled by the same signalling pathways. PLoS ONE 4, e6082 (2009).
60. Ly, T. et al. A proteomic chronology of gene expression through the cell cycle in human myeloid leukemia cells. eLife 3, e01630 (2014).
61. Bensaddek, D. et al. Micro-proteomics with iterative data analysis: proteome analysis in C. elegans at the single worm level. Proteomics 16, 381-392 (2016).
62. Cox, J. & Mann, M. MaxQuant enables high peptide identification rates, individualized p. p. b.-range mass accuracies and proteome-wide protein quantification. Nat. Biotechnol. 26, 1367-1372 (2008).
63. Aryee, M. J. et al. Minfi: a flexible and comprehensive Bioconductor package for the analysis of Infinium DNA methylation microarrays. Bioinformatics 30, 1363-1369 (2014).
64. Dobin, A. et al. STAR: ultrafast universal RNA-seq aligner. Bioinformatics 29, 15-21 (2013).
65. Anders, S., Pyl, P. T. & Huber, W. HTSeq-a Python framework to work with high-throughput sequencing data. Bioinformatics 31, 166-169 (2015).
66. Anders, S. & Huber, W. Differential expression analysis for sequence count data. Genome Biol. 11, R106 (2010).
67. DeLuca, D. S. et al. RNA-SeQC: RNA-seq metrics for quality control and process optimization. Bioinformatics 28, 1530-1532 (2012).
68. Leha, A. et al. A high-content platform to characterise human induced pluripotent stem cell lines. Methods 96, 85-96 (2016).
69. Zack, T. I. et al. Pan-cancer patterns of somatic copy number alteration. Nat. Genet. 45, 1134-1140 (2013).
70. Subramanian, A. et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc. Natl Acad. Sci. USA 102, 15545-15550 (2005).
71. Danecek, P. et al. The variant call format and VCFtools. Bioinformatics 27, 2156-2158 (2011).
72. Ritchie, M. E. et al. limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 43, e47 (2015).
73. Stegle, O., Parts, L., Durbin, R. & Winn, J. A Bayesian framework to account for complex non-genetic factors in gene expression levels greatly increases power in eQTL studies. PLOS Comput. Biol. 6, e1000770 (2010).
74. Lippert, C., Casale, F. P., Rakitsch, B. & Stegle, O. LIMIX: genetic analysis of multiple traits. Preprint at http://biorxiv. org/content/early/2014/05/21/003905 (2014).
75. Casale, F. P., Rakitsch, B., Lippert, C. & Stegle, O. Efficient set tests for the genetic analysis of correlated traits. Nat. Methods 12, 755-758 (2015).
76. Storey, J. D. & Tibshirani, R. Statistical significance for genomewide studies. Proc. Natl Acad. Sci. USA 100, 9440-9445 (2003).
77. Pers, T. H., Timshel, P. & Hirschhorn, J. N. SNPsnap: a web-based tool for identification and annotation of matched SNPs. Bioinformatics 31, 418-420 (2015).
78. Lawrence, M., Gentleman, R. & Carey, V. rtracklayer: an R package for interfacing with genome browsers. Bioinformatics 25, 1841-1842 (2009).
79. Farh, K. K. et al. Genetic and epigenetic fine mapping of causal autoimmune disease variants. Nature 518, 337-343 (2015).
80. Lambert, J. C. et al. Meta-analysis of 74, 046 individuals identifies 11 new susceptibility loci for Alzheimer's disease. Nat. Genet. 45, 1452-1458 (2013).
81. Trynka, G. et al. Dense genotyping identifies and localizes multiple common and rare variant association signals in celiac disease. Nat. Genet. 43, 1193-1201 (2011).
82. Liu, J. Z. et al. Association analyses identify 38 susceptibility loci for inflammatory bowel disease and highlight shared genetic risk across populations. Nat. Genet. 47, 979-986 (2015).
83. International Multiple Sclerosis Genetics Consortium (IMSGC). Analysis of immune-related loci identifies 48 new susceptibility variants for multiple sclerosis. Nat. Genet. 45, 1353-1360 (2013).
84. Faraco, J. et al. ImmunoChip study implicates antigen presentation to T cells in narcolepsy. PLoS Genet. 9, e1003270 (2013).
85. Cordell, H. J. et al. International genome-wide meta-analysis identifies new primary biliary cirrhosis risk loci and targetable pathogenic pathways. Nat. Commun. 6, 8019 (2015).
86. Tsoi, L. C. et al. Identification of 15 new psoriasis susceptibility loci highlights the role of innate immunity. Nat. Genet. 44, 1341-1348 (2012).
87. Okada, Y. et al. Genetics of rheumatoid arthritis contributes to biology and drug discovery. Nature 506, 376-381 (2014).
88. Schizophrenia Working Group of the Psychiatric Genomics Consortium. Biological insights from 108 schizophrenia-associated genetic loci. Nature 511, 421-427 (2014).
89. Bentham, J. et al. Genetic association analyses implicate aberrant regulation of innate and adaptive immunity genes in the pathogenesis of systemic lupus erythematosus. Nat. Genet. 47, 1457-1464 (2015).
90. Onengut-Gumuscu, S. et al. Fine mapping of type 1 diabetes susceptibility loci and evidence for colocalization of causal variants with lymphoid gene enhancers. Nat. Genet. 47, 381-386 (2015).
91. Morris, A. P. et al. Large-scale association analysis provides insights into the genetic architecture and pathophysiology of type 2 diabetes. Nat. Genet. 44, 981-990 (2012).
92. Li, Y. I. et al. RNA splicing is a primary link between genetic variation and disease. Science 352, 600-604 (2016).
93. Quinlan, A. R. & Hall, I. M. BEDTools: a flexible suite of utilities for comparing genomic features. Bioinformatics 26, 841-842 (2010).